The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
|Webcasts|October 7, 2020
Top 5 Strategies for Conducting an Effective Data Monitoring Committee (DMC)
Author(s)Advanced Clinical
***Live: Tuesday, October 27, 2020 at 11am EDT| 8am PDT| 3pm GMT| 4pm CET*** In this webinar we will discuss five areas of focus for conducting an effective DMC to ensure its success and deliver more value for sponsors, sites, and patients. ***On demand available after final airing until Oct. 27, 2021***
Register Free:
Event Overview:
Data monitoring committees (DMC) have always delivered a vital function in clinical research. The independent assessment of the safety, scientific validity, and integrity of clinical trials provides an unbiased view of the trial. When these boards meet regularly, and have the time, talent, and resources to effectively monitor a trial, they help sponsors make more effective decisions about whether a study should continue, what changes can be made to the study design, and other critical details to make the trial more effective.
However, DMCs are sometimes not conducted effectively and face challenges that can lead to errors, missed opportunities, and delays in decision-making. These challenges range from scheduling, programming errors, and budgeting issues, to misalignment with sponsors, all of which can compromise data integrity and weaken the effectiveness of the committee.
In this webinar, we will discuss the most effective ways to conduct a DMC to ensure to deliver more value for sponsors, sites, and patients.
Key Learning Objectives:
- DMC basics – What a DMC is, who belongs on the DMC, and the role they play in the trial
- Common challenges in DMC setup including member selection, timely charter development, and setting scheduling expectations
- The impact of incomplete data management
- How to avoid challenges through effective communication and setting clear expectations
Speakers: Tracy Parker, VP, Biometrics, Advanced Clinical
Jason Piontek, Director SAS Programming, Advanced Clinical
Time and Date: Tuesday, October 27, 2020 at 11am EDT| 8am PDT| 3pm GMT| 4pm CET
On demand available after final airing until Oct. 27, 2021
Register Free:
Related to this article
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Syneos Health and Optum outline a joint model for trial planning, recruitment and site access, with no financial terms or timelines disclosed.
AstraZeneca and Oracle Outline AI Collaboration for Clinical Trial Recruitment and Safety Monitoring
What sponsors and sites should know about the AstraZeneca-Oracle AI collaboration on trial recruitment, safety monitoring and data governance.
Trending on Applied Clinical Trials Online
1
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
2
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
3
Where AI Governance in Clinical Development Falls Short
4
Syneos Health, Optum Partner on Adaptive Clinical Development Model
5